Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Survival analysis across the entire transcriptome identifies biomarkers with the highest prognostic power in breast cancer

1 Jan 2021

Abstract excerpt

INTRODUCTION: Extensive research is directed to uncover new biomarkers capable to stratify breast cancer patients into clinically relevant cohorts. However, the overall performance ranking of such marker candidates compared to other genes is virtually absent. Here, we present the ranking of all survival related genes in chemotherapy treated basal and estrogen positive/HER2 negative breast cancer. METHODS: We...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Cancer Treatment Studies
Share to Clusterin in disease pathology
Share to Ferroptosis and cancer prognosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34527184
DOI: 10.1016/j.csbj.2021.07.014

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Survival analysis across the entire transcriptome identifies biomarkers with the highest prognostic power in breast cancerPMID 34527184Read ↗

Development and External Validation of a Transcriptomic Prognostic Signature in Triple-Negative Breast Cancer Treated with Neoadjuvant ChemotherapySemantic proximity Read ↗

Molecular Classification of Breast Cancer Utilizing Long Non-Coding RNA (lncRNA) Transcriptomes Identifies Novel Diagnostic lncRNA Panel for Triple-Negative Breast CancerSemantic proximity Read ↗

Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment StrategiesSemantic proximity Read ↗

Breast cancer survival prediction using seven prognostic biomarker genesSemantic proximity Read ↗

Identification of genes associated with survival of breast cancer patientsSemantic proximity Read ↗

The Early-Stage Triple-Negative Breast Cancer Landscape Derives a Novel Prognostic Signature and Therapeutic TargetSemantic proximity Read ↗

Transcriptional Shift Identifies a Set of Genes Driving Breast Cancer ChemoresistanceSemantic proximity Read ↗

Gene Pathways Associated With Prognosis and Chemotherapy Sensitivity in Molecular Subtypes of Breast CancerSemantic proximity Read ↗

Transcriptomic Analysis of Breast Cancer Patients Sensitive and Resistant to Chemotherapy: Looking for Overall Survival and Drug Resistance BiomarkersSemantic proximity Read ↗

Prognostic analysis of patients with breast cancer based on tumor mutational burden and DNA damage repair genesSemantic proximity Read ↗

Novel Gene Signatures Predictive of Patient Recurrence-free Survival in HR+HER2- Breast CancerSemantic proximity Read ↗

Basal-like breast cancer: molecular profiles, clinical features and survival outcomesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.